Cargando…
Relation Between Gender and Concomitant Medications With Erythropoietin-Treatment on Wound Healing in Burn Patients. Post Hoc Subgroup-Analysis of the Randomized, Placebo-Controlled Clinical Trial “EPO in Burns”
Burns are leading causes of mortality and morbidity, including prolonged hospitalization, disfigurement, and disability. Erythropoietin (EPO) is a well-known hormone causing erythropoiesis. However, EPO may play a role in healing acute and chronic wounds due to its anti-inflammatory and pro-regenera...
Autores principales: | Günter, Christina Irene, Ilg, Felicitas Paula, Hapfelmeier, Alexander, Egert-Schwender, Silvia, Jelkmann, Wolfgang, Giri, Shibashish, Bader, Augustinus, Machens, Hans-Günter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284535/ https://www.ncbi.nlm.nih.gov/pubmed/35847006 http://dx.doi.org/10.3389/fphar.2022.812888 |
Ejemplares similares
-
A Randomized Controlled Trial: Regenerative Effects, Efficacy and Safety of Erythropoietin in Burn and Scalding Injuries
por: Günter, Christina I., et al.
Publicado: (2018) -
Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO
por: Bader, Augustinus, et al.
Publicado: (2012) -
Therapy of an incomplete spinal cord injury by intrathecal injection of EPO and subcutaneous injection of EPO, vitamin C and G-CSF
por: Bader, Augustinus, et al.
Publicado: (2017) -
A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trial
por: Günter, Christina Irene, et al.
Publicado: (2013) -
Skin regeneration in deep second-degree scald injuries either by infusion pumping or topical application of recombinant human erythropoietin gel
por: Giri, Priya, et al.
Publicado: (2015)